Press release
U.S. Ketamine Clinics Market Size, Emerging Trends, Industry Leaders and Report 2023-2028
U.S. Ketamine Clinics Market Report 2023
The U.S. ketamine clinics market size reached US$ 3.24 Billion in 2022 and is expected to reach US$ 5.91 Billion by 2028, exhibiting a growth rate (CAGR) of 10.60% during 2023-2028.
What is Ketamine Clinics?
Ketamine clinics are medical facilities that specialize in the administration of ketamine, which is a powerful anesthetic and analgesic medication. These clinics are known for their use of ketamine in the treatment of various mental health conditions, such as depression, anxiety, and post-traumatic stress disorder (PTSD). At a ketamine clinic, trained medical professionals carefully administer ketamine through intravenous (IV), intramuscular (IM), or nasal spray routes, typically in low doses. The treatment is often referred to as ketamine therapy or infusion therapy, which is used off-label for mental health conditions when other treatments have proven ineffective. Moreover, ketamine clinics help individuals feel relief through ketamine therapy who have not responded to traditional antidepressants. As ketamine clinics prioritize patient safety, monitoring, and a controlled environment to minimize potential side effects and ensure a positive experience, their demand is rising in the US.
Request for a PDF sample of this report: https://www.imarcgroup.com/us-ketamine-clinics-market/requestsample
U.S. Ketamine Clinics Market Trends and Drivers:
The increasing prevalence of mental health conditions like depression, anxiety, and post-traumatic stress disorder (PTSD) is creating a substantial demand for innovative treatments in the US. Ketamine is showing rapid and often effective results in treating these conditions, driving patients and healthcare providers to explore its potential. In addition, ketamine offers hope for individuals with treatment-resistant depression, leading them to seek out specialized ketamine clinics for alternative solutions in the US. Besides this, the increasing awareness about the benefits of ketamine therapy is encouraging more patients to seek this treatment option. Word-of-mouth recommendations, testimonials, and media coverage are contributing to a higher level of public awareness in the country. Moreover, the training of medical professionals to administer ketamine therapy safely is leading to an increase in the number of clinics offering these services, improving accessibility for patients. In line with this, some insurance providers in the US are starting to cover ketamine therapy for certain conditions. This development is making the treatment more affordable and accessible to a broader patient population in the country.
Read Full Report: https://www.imarcgroup.com/us-ketamine-clinics-market
What Is Included In Market Segmentation?
The report has segmented the market into the following categories:
Breakup by Treatment:
• Depression
• Anxiety
• PTSD
• Others
Breakup by Therapy:
• On-Site Therapy
• Online Therapy
Breakup by Region:
• Northeast
• Midwest
• South
• West
Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=8356&flag=C
The report provides a comprehensive analysis of the industry key players listed below:
• Better U LLC
• Field Trip Health and Wellness Ltd.
• Innerwell
• Ketamine Clinics Los Angeles
• Klarisana - Ketamine Treatment Austin
• Klarity Clinic
• Mindbloom Inc.
• Nue Life Health PBC
• NY Ketamine Infusions
• Vitalitas Denver
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Ketamine Clinics Market Size, Emerging Trends, Industry Leaders and Report 2023-2028 here
News-ID: 3255950 • Views: …
More Releases from IMARC Group
Setup Report on Asphalt Manufacturing Plant 2025: Feasibility Study and Profitab …
Asphalt is a specialized construction material designed to provide durable surfacing for roads, highways, and infrastructure projects, ensuring efficient pavement performance and extended operational life. This material is typically a hot-mix composition of aggregates and bitumen that balances structural strength with flexibility to support traffic loads, weather resistance, and longevity. Its quality directly influences pavement durability, safety, and overall infrastructure efficiency.
Setting up an asphalt manufacturing plant involves establishing facilities for…
Setting Up a Neem Oil Processing Plant 2025: Cost, Key Insights and Investment O …
Neem oil is a specialized natural product designed to provide solutions for agricultural, pharmaceutical, and cosmetic applications, ensuring efficient pest management and extended crop protection time. This oil is typically lightweight, high-potency botanical extract that balances active compound concentration with purity to support pest control effectiveness, therapeutic properties, and product stability. Its quality directly influences application efficacy, safety, and overall product performance.
Setting up a neem oil processing plant involves establishing…
How to Setup Chocolate Manufacturing Plant 2025: Complete Investment Guide for I …
Chocolate is a specialized confectionery product designed to provide taste satisfaction and sensory pleasure for consumers, ensuring delightful eating experience and extended shelf life. These products are typically smooth-textured, high-quality cocoa-based confections that balance flavor profile with consistency to support taste appeal, texture quality, and freshness. Their quality directly influences consumer satisfaction, safety, and overall product excellence.
Setting up a chocolate manufacturing plant involves establishing facilities for cocoa processing, conching, and…
India Sand Market Size to Hit USD 958.0 Million (5.10% CAGR) by 2033 | Get Free …
According to IMARC Group's report titled "India Sand Market Size, Share, Trends and Forecast by Type, Application, and Region, 2025-2033", The report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights.
Short Summary:
The India sand market size reached USD 582.6 Million in 2024 and is projected to reach USD 958.0 Million by 2033, growing at a CAGR of 5.10% (2025-2033). The market expansion is driven…
More Releases for Ketamine
Ketamine Treatment Market Growth by Top Company, Product Price, Profit
The Ketamine Treatment Market was valued at USD 4.33 Bn in 2024, and total global Ketamine Treatment Market revenue is expected to grow at a CAGR of 11.7% & reaching nearly USD 10.49 Bn from 2025-2032
Ketamine Treatment Market Overview:
The Ketamine Treatment Market is witnessing strong growth as ketamine emerges as a transformative therapy for mental health disorders, including depression, anxiety, and PTSD. Increasing acceptance of ketamine-based treatments in clinical settings,…
Ketamine-Assisted Therapy in Bethesda MD: A Compassionate Alternative to Traditi …
Ketamine-assisted therapy at Calliope Health Ketamine in Bethesda MD offers a caring and therapeutic alternative for those who haven't found relief through traditional treatment. By combining ketamine infusion with emotional support and psychotherapy, individuals gain a safe space to process feelings, reconnect with themselves, and move toward meaningful healing-not just symptom management.
There comes a point when someone who has been trying their best-showing up for therapy, taking their prescribed medications,…
Breakthroughs in Mental Health: Calliope Health Ketamine Expands Access to Ketam …
In recent years, the landscape of mental health treatment has seen remarkable advancements, with innovative therapies offering new hope to those battling conditions like depression, anxiety, and PTSD. Among these breakthroughs, ketamine therapy has emerged as a powerful option, providing rapid relief for individuals who have not responded to traditional treatments. Calliope Health Ketamine is at the forefront of this movement, expanding access to ketamine therapy in Maryland, where it…
Ketamine treatment Market 2023 Driving Factors Forecast Research 2029
Ketamine treatment market is anticipated to grow at a CAGR of 43.74% during the forecast period (2023-2030). The market's growth is attributed to prevalence of treatment-resistant depression. A considerable number of individuals with MDD do not respond to standard therapies, resulting in a patient group known as TRD. This population has a significant unmet medical need. Ketamine's ability to bring relief to TRD sufferers has resulted in its increased use…
Ketamine treatment Market 2023 Driving Factors Forecast Research 2029
Ketamine treatment market is anticipated to grow at a CAGR of 43.74% during the forecast period (2023-2030). The market's growth is attributed to prevalence of treatment-resistant depression. A considerable number of individuals with MDD do not respond to standard therapies, resulting in a patient group known as TRD. This population has a significant unmet medical need. Ketamine's ability to bring relief to TRD sufferers has resulted in its increased use…
Ketamine Treatment Market to Witness Astonishing Growth by 2029
The global ketamine treatment market is anticipated to grow at a CAGR of 43.7% during the forecast period (2023-2030). Ketamine has been widely used in the treatment of various conditions, including major depressive disorder, treatment-resistant depression (TRD), bipolar depression, post-traumatic stress disorder, anxiety disorders, chronic pain management, and migraine or headache management. Ketamine is also been used in the form of infusion therapy and nasal spray, and has been found…
